www.pharming.com Open in urlscan Pro
34.230.103.148  Public Scan

Form analysis
2 forms found in the DOM

/search

<form action="/search" class="navbar-form form-inline validate" id="headerSearchform" novalidate="novalidate">
  <div class="form-group">
    <label for="#keywords" class="d-none"> Search </label>
    <input class="form-control required" type="text" placeholder="What are you looking for?" name="keywords" minlength="2" autocomplete="off">
    <span class="far fa-search"></span>
    <button class="btn btn-primary" type="submit"> Search </button>
  </div>
</form>

<form id="sg-widget" data-token="4fa23942806fd52c07ca8cd9a088ede0" onsubmit="return false;" class="newsletter-form validate" novalidate="novalidate">
  <fieldset>
    <div class="form-group radio-group">
      <div class="form-group radio-group form-check form-check-inline">
        <input class="form-radio form-control" checked="" type="radio" name="language" id="lang-en-footer" value="en">
        <label class="" for="lang-en-footer"> English </label>
      </div>
      <div class=" form-check form-check-inline">
        <input class="form-radio form-control" type="radio" name="language" id="lang-nl-footer" value="nl">
        <label class="" for="lang-nl-footer"> Dutch </label>
      </div>
    </div>
    <div class="form-group">
      <label for="sg_email" class="d-none"> Sign up </label>
      <input id="sg_email" type="email" name="sg_email" placeholder="Email address" required="" class="form-control required email" autocomplete="email" data-msg="This field is required" data-email="Please fill in a correct email address">
      <input type="submit" id="sg-submit-btn" value="Signup" class="btn button">
      <input type="submit" id="custom-submit" value="Signup" class="btn button" style="display: none;">
      <div class="sg-response" id="sg-response"></div>
    </div>
    <div class="form-group checkbox-group">
      <input type="checkbox" id="sg_consent_checkbox" class="required" name="sg_consent_checkbox" data-msg="This field is required" required="">
      <label for="sg_consent_checkbox"> I understand and consent to the following <a target="_blank" href="/privacy-statement">
															Privacy Statement
														</a>
      </label>
    </div>
  </fieldset>
</form>

Text Content

Close
Menu
 * Home
 * Open submenu (About Us)About Us
 * Products
 * Pipeline
 * Open submenu (Investors)Investors
 * News
 * Careers
 * Contact
 * LanguageVerander taal

Close submenu (About Us)About Us
 * Open submenu (Executive Committee)Executive Committee
 * Open submenu (Board of Directors)Board of Directors
 * Corporate Governance
 * Partnering

Close submenu (Executive Committee)Executive Committee
 * Sijmen de Vries
 * Jeroen Wakkerman
 * Anurag Relan
 * Stephen Toor
 * Mireille Sanders, MSc
 * Ruud van Outersterp
 * Dr. Alexander Breidenbach
 * Daniela Dos Anjos Hanova

Close submenu (Board of Directors)Board of Directors
 * Deborah Jorn, MBA
 * Barbara Yanni
 * Mark Pykett, VMD, PhD
 * Leonard Kruimer
 * Jabine van der Meijs
 * Richard Peters, MD, PhD
 * Steven Baert

Close submenu (Investors)Investors
 * Upcoming events
 * Corporate Presentations
 * Shareholder Meetings
 * Financial documents
 * Analyst Coverage
 * SEC filings
 * FAQ

Skip to main content
Search Search


PHARMING

Search Menu
global
 * Home
 * About Us
   * Executive Committee
   * Board of Directors
   * Corporate Governance
   * Partnering
 * Products
 * Pipeline
 * Investors
   * Upcoming events
   * Corporate Presentations
   * Shareholder Meetings
   * Financial documents
   * Analyst Coverage
   * SEC filings
   * FAQ
 * News
 * Careers
 * Contact
 * Search LanguageVerander taal




SERVING THE UNSERVED RARE DISEASE PATIENT

A global biopharmaceutical company developing and commercializing innovative
protein replacement therapies and precision medicines to serve the unserved rare
disease patient.

Read more



HIGHLIGHTS

Pharming Group announces development plans for leniolisib for additional primary
immunodeficiencies (PIDs)
 * Clinical trials
 * December 13 2023

Read more
Pharming announces first patient dosed in pediatric clinical trial for children
aged 1 to 6 years for leniolisib
 * Clinical trials
 * November 21 2023

Read more
Pharming Group provides updates on EMA regulatory review of leniolisib MAA and
plans to file for UK regulatory approval
 * Corporate updates
 * November 10 2023

Read more
Read more news


UPDATES

Upcoming Events

View our financial calendar and what conferences, meetings, and congresses we
will visit in 2023 on our Upcoming Events page.

Read more
Corporate Presentations

Download Pharming's most recent quarterly financial results and conference
presentations on our Corporate Presentations page.

Read more


CAREER OPPORTUNITIES

We are an open organization with ambitious and passionate people who are
committed to the company, the colleagues and the patients we serve and are
continuously looking for highly talented and motivated individuals to join our
team.

Please take a look at our vacancies or send us an open application. We look
forward to receiving your CV and motivation letter.

Career opportunities

Cookies: This website uses cookies Check the cookies page for more information
Accept Decline
 * Contact
 * +31 (0)71 5247 400 +31 (0)71 5247 400
 * +31 (0)71 5247 445
 * info@pharming.com

 * Visiting address
 * Pharming Group N.V.
 * Vondellaan 47
 * 2332 AA Leiden
 * The Netherlands

 * Postal address
 * Pharming Group N.V.
 * Darwinweg 24
 * 2333 CR Leiden
 * The Netherlands

Subscribe to our press release distribution list Stay up to date on the latest
news and information
English
Dutch
Sign up

I understand and consent to the following Privacy Statement
 * About us
 * Executive Committee
 * Board of Directors
 * Corporate Governance
 * Partnering

 * PRODUCTS

 * Pipeline

 * Investors
 * Upcoming Events
 * Past Events
 * Corporate Presentations
 * Shareholder Meetings

 * >>
 * Financial Documents
 * Analyst Coverage
 * SEC Filings
 * FAQ

 * News
 * Careers
 * Contact

 * Visit our LinkedIn page
 * Report an adverse event
 * Corporate governance
 * Privacy statement
 * Disclaimer
 * Cookie Statement
 * Terms & Conditions
 * © Pharming 2023


TAAL AANPASSEN

Wilt u overschakelen naar een andere taal? Klik hier voor de Nederlandse
website.

Taal aanpassen Sluiten